基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 抗生素类药物 氨基糖苷类药 新霉素标液 新霉素B
  • 新霉素B|T15348|TargetMol

新霉素B|T15348|TargetMol

Framycetin
119-04-0
17500 500mg 起订
上海 更新日期:2025-08-20

TargetMol中国(陶术生物)

VIP2年
联系人:邵小姐
手机:15002134094 拨打
邮箱:marketing@targetmol.cn

产品详情:

中文名称:
新霉素B
英文名称:
Framycetin
CAS号:
119-04-0
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature.
产品类别:
抑制剂
货号:
T15348

Product Introduction

Bioactivity

名称Framycetin
描述Framycetin is an aminoglycoside antibiotic and it also inhibits hammerhead ribozyme (Ki: 13.5 μM).
体外活性Neomycin B targets the bacterial and human ribosomes and affects translation. Neomycin B is used clinically to treat hepatic encephalopathy (by reducing ammonium levels in the gut) and enteropathogenic Escherichia coli infections. The addition of neomycin B, to an HCC cell line, selectively inhibits the production of the mature miRNA, boosts a downstream protein, and inhibits invasion [2]. The aminoglycoside antibiotic neomycin B causes misreading of the genetic code during translation and inhibits several ribozymes. The ribosomal target site of neomycin B is the 16 S rRNA 1400 to 1500 region, which has been clearly demonstrated by dissecting this domain from a small RNA of 27 nucleotides. This small subdomain of the 16 S rRNA is protected from chemical modification by neomycin at the same positions as in the context of the 30 S subunit [4]. Neomycin B interacts with various target RNAs that have no primary sequence homology. This means that the drug binds to a structural rather than a sequence motif of the RNA. Its primary cognate target is the decoding site of the 16S rRNA, but it also binds to the Rev-responsive element in HIV-1, a group I introns, and the hammerhead ribozyme, and thus inhibits their biological function [3].
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature.
溶解度DMSO : 50 mg/mL (81.35 mM), Sonication is recommended.
H2O : 100 mg/mL (162.70 mM), Sonication is recommended.
关键字hammerhead ribozyme | Framycetin
新霉素B|||Neomycin B|||Fradiomycin B|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (13年)
注册资本 589.8595万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,天然产物,生物化工,化学试剂,生物技术服务

新霉素B相关厂家报价

内容声明
拨打电话 立即询价